CV Sciences, Inc. Logo
  • Home
  • About Us
    • Clinical Pipeline
    • Management Team
    • Board Of Directors
    • History
  • Pipeline
  • Consumer Products
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us

Investors

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

Press Releases

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

Mar 24, 2023

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

Mar 23, 2023

CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels

Mar 21, 2023

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

Mar 2, 2023

CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

Jan 19, 2023

CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

Jan 18, 2023

CV Sciences, Inc. Reports Third Quarter 2022 Financial Results

Nov 14, 2022

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

Nov 8, 2022

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

Sep 27, 2022

CV Sciences, Inc. Extinguishes Convertible Debt

Aug 25, 2022
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...21
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

© CV Sciences, Inc. All Rights Reserved.

  • Home
  • About Us
    ▼
    • Clinical Pipeline
    • Management Team
    • Board Of Directors
    • History
  • Pipeline
  • Consumer Products
  • Investors
    ▼
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us